risperidon sandoz 0.5 mg
sandoz as - risperidon - tablett, filmdrasjert - 0.5 mg
wellbutrin retard 300 mg
glaxosmithkline as - bupropionhydroklorid - tablett med modifisert frisetting - 300 mg
wellbutrin retard 150 mg
glaxosmithkline as - bupropionhydroklorid - tablett med modifisert frisetting - 150 mg
zolpidem aurobindo 10 mg
aurobindo pharma (malta) limited - zolpidemtartrat - tablett, filmdrasjert - 10 mg
zolpidem aurobindo 5 mg
aurobindo pharma (malta) limited - zolpidemtartrat - tablett, filmdrasjert - 5 mg
lorviqua
pfizer europe ma eeig - lorlatinib - karsinom, ikke-småcellet lunge - antineoplastic agents, protein kinase inhibitors - lorviqua as monotherapy is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. lorviqua as monotherapy is indicated for the treatment of adult patients with alk‑positive advanced nsclc whose disease has progressed after:alectinib or ceritinib as the first alk tyrosine kinase inhibitor (tki) therapy; orcrizotinib and at least one other alk tki.
paritdam 300 mg
accord healthcare b.v. - bupropionhydroklorid - tablett med modifisert frisetting - 300 mg
bugnanto 30 mikrog/ time
sandoz - københavn - buprenorfin - depotplaster - 30 mikrog/ time
paritdam 150 mg
accord healthcare b.v. - bupropionhydroklorid - tablett med modifisert frisetting - 150 mg
numient
amneal pharma europe ltd - levodopa, carbidopa - parkinsonsykdom - anti-parkinson medisiner - symptomatisk behandling av voksne pasienter med parkinsons sykdom.